Mostrar el registro sencillo del ítem
Systematic review and meta-analysis appraising efficacy and safety of adrenaline for adult cardiopulmonary resuscitation
dc.contributor.author | Ludwin, K. | |
dc.contributor.author | Safiejko, K. | |
dc.contributor.author | Smereka, J. | |
dc.contributor.author | Nadolny, K. | |
dc.contributor.author | Cyran, M. | |
dc.contributor.author | Yakubtsevich, R. | |
dc.contributor.author | Jaguszewski, M. J. | |
dc.contributor.author | Filipiak, K. J. | |
dc.contributor.author | Szarpak, L. | |
dc.contributor.author | Rodríguez Núñez, Antonio | |
dc.date.accessioned | 2022-04-26T07:43:28Z | |
dc.date.available | 2022-04-26T07:43:28Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1897-5593 | |
dc.identifier.other | https://www.ncbi.nlm.nih.gov/pubmed/33140398 | es |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/16529 | |
dc.description.abstract | BACKGROUND: There is a beneficial effect of adrenaline during adult cardiopulmonary resuscitation (CPR) from cardiac arrest but there is also uncertainty about its safety and effectiveness. The aim of this study was to evaluate the use of adrenaline versus non-adrenaline CPR. METHODS: PubMed, ScienceDirect, Embase, CENTRAL (Cochrane Central Register of Controlled Trials) and Google Scholar databases were searched from their inception up to 1st July 2020. Two reviewers independently assessed eligibility and risk of bias, with conflicts resolved by a third reviewer. Risk ratio (RR) or mean difference of groups were calculated using fixed or random-effect models. RESULTS: Nineteen trials were identified. The use of adrenaline during CPR was associated with a significantly higher percentage of return of spontaneous circulation (ROSC) compared to non-adrenaline treatment (20.9% vs. 5.9%; RR = 1.87; 95% confidence interval [CI] 1.37-2.55; p < 0.001). The use of adrenaline in CPR was associated with ROSC at 19.4% and for non-adrenaline treatment - 4.3% (RR = 3.23; 95% CI 1.89-5.53; p < 0.001). Survival to discharge (or 30-day survival) when using adrenaline was 6.8% compared to non-adrenaline treatment (5.5%; RR = 0.99; 95% CI 0.76-1.30; p = 0.97). However, the use of adrenaline was associated with a worse neurological outcome (1.6% vs. 2.2%; RR = 0.57; 95% CI 0.42-0.78; p < 0.001). CONCLUSIONS: This review suggests that resuscitation with adrenaline is associated with the ROSC and survival to hospital discharge, but no higher effectiveness was observed at discharge with favorable neurological outcome. The analysis showed higher effectiveness of ROSC and survival to hospital discharge in non-shockable rhythms. But more multicenter randomized controlled trials are needed in the future. | en |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.mesh | Humans | * |
dc.subject.mesh | Multicenter Studies as Topic | * |
dc.subject.mesh | Patient Discharge | * |
dc.title | Systematic review and meta-analysis appraising efficacy and safety of adrenaline for adult cardiopulmonary resuscitation | en |
dc.type | Journal Article | es |
dc.authorsophos | Ludwin, K.;Safiejko, K.;Smereka, J.;Nadolny, K.;Cyran, M.;Yakubtsevich, R.;Jaguszewski, M. J.;Filipiak, K. J.;Szarpak, L.;Rodríguez-Núñez, A. | |
dc.identifier.doi | 10.5603/CJ.a2020.0133 | |
dc.identifier.pmid | 33140398 | |
dc.identifier.sophos | 39192 | |
dc.issue.number | 2 | es |
dc.journal.title | Cardiology Journal | es |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Pediatría | es |
dc.page.initial | 279 | es |
dc.page.final | 292 | es |
dc.rights.accessRights | openAccess | |
dc.subject.decs | estudios multicéntricos como asunto | * |
dc.subject.decs | humanos | * |
dc.subject.decs | alta de pacientes | * |
dc.subject.keyword | CHUS | es |
dc.typefides | Artículo de Revisión | es |
dc.typesophos | Artículo de Revisión | es |
dc.volume.number | 28 | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International
![](/xmlui/themes/Mirage2//images/final_lines.png)